BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33726796)

  • 1. YAP promotes autophagy and progression of gliomas via upregulating HMGB1.
    Zhao M; Zhang Y; Jiang Y; Wang K; Wang X; Zhou D; Wang Y; Yu R; Zhou X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):99. PubMed ID: 33726796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine Pathway.
    Cheng P; Ma Y; Gao Z; Duan L
    Med Sci Monit; 2018 Dec; 24():8916-8924. PubMed ID: 30531692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1-Induced p62 Overexpression Promotes Snail-Mediated Epithelial-Mesenchymal Transition in Glioblastoma Cells via the Degradation of GSK-3β.
    Li H; Li J; Zhang G; Da Q; Chen L; Yu S; Zhou Q; Weng Z; Xin Z; Shi L; Ma L; Huang A; Qi S; Lu Y
    Theranostics; 2019; 9(7):1909-1922. PubMed ID: 31037147
    [No Abstract]   [Full Text] [Related]  

  • 4. HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells.
    Chai W; Ye F; Zeng L; Li Y; Yang L
    J Exp Clin Cancer Res; 2019 Jul; 38(1):325. PubMed ID: 31331356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BEX1 and BEX4 Induce GBM Progression through Regulation of Actin Polymerization and Activation of YAP/TAZ Signaling.
    Lee S; Kang H; Shin E; Jeon J; Youn H; Youn B
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
    Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
    Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
    Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
    Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.
    Artinian N; Cloninger C; Holmes B; Benavides-Serrato A; Bashir T; Gera J
    J Biol Chem; 2015 Aug; 290(32):19387-401. PubMed ID: 25998128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircCDC45 promotes the malignant progression of glioblastoma by modulating the miR-485-5p/CSF-1 axis.
    Liu R; Dai W; Wu A; Li Y
    BMC Cancer; 2021 Oct; 21(1):1090. PubMed ID: 34627193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway.
    Xu Y; Sun Q; Yuan F; Dong H; Zhang H; Geng R; Qi Y; Xiong X; Chen Q; Liu B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):174. PubMed ID: 32867814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXO4 expression associates with glioblastoma development and FOXO4 expression inhibits cell malignant phenotypes in vitro and in vivo.
    Qi M; Sun LA; Jiang XC; Han YL; Wang L; Niu WH; Fei MX; Zhaba WD; Zheng LR; Zhou ML
    Life Sci; 2020 Apr; 247():117436. PubMed ID: 32070707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
    Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
    Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
    Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis.
    Liu Z; Yee PP; Wei Y; Liu Z; Kawasawa YI; Li W
    J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30665893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy.
    Ma H; Zheng S; Zhang X; Gong T; Lv X; Fu S; Zhang S; Yin X; Hao J; Shan C; Huang S
    Cell Death Dis; 2019 Feb; 10(2):136. PubMed ID: 30755598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
    Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
    Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy.
    Liu WM; Huang P; Kar N; Burgett M; Muller-Greven G; Nowacki AS; Distelhorst CW; Lathia JD; Rich JN; Kappes JC; Gladson CL
    PLoS One; 2013; 8(8):e70804. PubMed ID: 23936469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB3 facilitates glioblastoma progression via restraining autophagy.
    Tang Z; Chen H; Zhong D; Wei W; Liu L; Duan Q; Han B; Li G
    Aging (Albany NY); 2020 Nov; 12(24):25020-25034. PubMed ID: 33203798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
    Vigneswaran K; Boyd NH; Oh SY; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
    Clin Cancer Res; 2021 Mar; 27(5):1553-1569. PubMed ID: 33172899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.
    Meng D; Chen Y; Yun D; Zhao Y; Wang J; Xu T; Li X; Wang Y; Yuan L; Sun R; Song X; Huai C; Hu L; Yang S; Min T; Chen J; Chen H; Lu D
    Oncotarget; 2015 Mar; 6(7):4901-19. PubMed ID: 25669971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.